Medicine Man Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medicine Man Technologies generated cash of $12,200,963, which is more than the previous year. Cash used in financing activities reached the amount of -$5,463,196 last year. Net change in cash is therefore -$19,700,321.
Cash Flow
| 2014 | -205.49K | 0 | 260K |
|---|---|---|---|
| 2015 | 301.84K | -104.20K | 10K |
| 2016 | -741.47K | 20.85K | 810K |
| 2017 | -673.99K | -33.90K | 1.10M |
| 2018 | 1.28M | -149.88K | 1M |
| 2019 | -7.55M | -1.11M | 20.20M |
| 2020 | -9.79M | -33.21M | 31.90M |
| 2021 | 57.33M | -81.16M | 128.99M |
| 2022 | 11.39M | -79.18M | 337.37K |
| 2023 | 12.20M | -26.43M | -5.46M |
SHWZ Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 38.94M | 106.40M | 1.23M | 12.34M | 321.78K | 748.71K | 351.52K | 262.14K | 54.51K | 0 |
Operating activities | ||||||||||
Net income | -34.54M | -18.46M | 14.51M | -19.41M | -16.97M | 948.91K | -5.38M | -1.46M | 85.74K | -29.95K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 20.93M | 11.01M | 8.57M | 476.59K | 61.70K | 81.96K | 63.73K | 17.37K | 6.61K | 561 |
Stock-based compensation expense | 3.59M | 812.07K | 5.03M | 8.23M | 7.18M | 0 | 4.80M | 627.2K | 79.72K | 54.19K |
| Deferred income tax benefit | 3.59M | 812.07K | 5.03M | 8.23M | 7.18M | 0 | 4.80M | 627.2K | 79.72K | 54.19K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 927.25K | 467.69K | 244.92K | 874.61K | -3.36M | -2.10M | -462.06K | 58.73K | -83.73K | 0 |
Inventories | 4.57M | 789.39K | -4.70M | 781.51K | -195.70K | -383.14K | -106.09K | -1.78K | -29.84K | 0 |
Accounts payable | -3.24M | 8.20M | 493.71K | 1.61M | 1.24M | 812.91K | 334.74K | -8.71K | -9.78K | 18.5K |
Cash generated by operating activities | 12.20M | 11.39M | 57.33M | -9.79M | -7.55M | 1.28M | -673.99K | -741.47K | 301.84K | -205.49K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -2M | 0 | 0 | 0 | -71.56K | 217.45K | 31.69K | -50K | 0 |
Investments In Property Plant And Equipment | -7.86M | -14.81M | -5.66M | -768.17K | -200.23K | -20.03K | -255.66K | -10.84K | -54.20K | 0 |
Acquisitions Net | -15.83M | -62.37M | -75.67M | -33.27M | 0 | -71.56K | 38.20K | 0 | 0 | 0 |
Cash generated by investing activities | -26.43M | -79.18M | -81.16M | -33.21M | -1.11M | -149.88K | -33.90K | 20.85K | -104.20K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 978.30K | 50.28M | 12.62M | 19.6M | 1M | 1.18M | 0 | 10K | 260K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -108.97K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -5.35M | -134.49K | -4.86M | -18.90M | 0 | 0 | -80.66K | 0 | 0 | 0 |
Cash used in financing activities | -5.46M | 337.37K | 128.99M | 31.90M | 20.20M | 1M | 1.10M | 810K | 10K | 260K |
Net Change In Cash | -19.70M | -67.45M | 105.16M | -11.11M | 11.53M | -426.92K | 397.19K | 89.37K | 207.63K | 54.51K |
Cash at end of period | 19.24M | 38.94M | 106.40M | 1.23M | 11.85M | 321.78K | 748.71K | 351.52K | 262.14K | 54.51K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |